Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bioaffinity Technologies Inc (BIAF)

Bioaffinity Technologies Inc (BIAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,829
  • Shares Outstanding, K 4,499
  • Annual Sales, $ 9,360 K
  • Annual Income, $ -9,040 K
  • EBIT $ -10 M
  • EBITDA $ -9 M
  • 60-Month Beta 2.44
  • Price/Sales 0.09
  • Price/Cash Flow N/A
  • Price/Book 0.38
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -17.71
  • Most Recent Earnings $-2.70 on 11/14/25
  • Next Earnings Date 03/30/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6930 +22.83%
on 02/05/26
1.4800 -42.49%
on 01/16/26
-0.4388 (-34.02%)
since 01/06/26
3-Month
0.6930 +22.83%
on 02/05/26
2.2500 -62.17%
on 11/12/25
-1.1988 (-58.48%)
since 11/06/25
52-Week
0.6930 +22.83%
on 02/05/26
46.5300 -98.17%
on 04/01/25
-24.3488 (-96.62%)
since 02/06/25

Most Recent Stories

More News
bioAffinity Technologies’ Laboratory Maintains Prestigious College of American Pathologists (CAP) Accreditation

CyPath® Lung addresses urgent unmet need in projected $10.4 billion lung cancer diagnostic market by 2034 Precision Pathology Laboratory Services meets...

BIAF : 0.8512 (+13.49%)
BIAFW : 0.3100 (-8.82%)
bioAffinity Technologies’ Noninvasive CyPath® Lung Test to Be Highlighted at American Cancer Society National Lung Cancer Roundtable

bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW) , a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today announced...

BIAF : 0.8512 (+13.49%)
BIAFW : 0.3100 (-8.82%)
bioAffinity Technologies Reports Third Quarter 2025 Financial Results

Company achieves 86% increase in CyPath® Lung testing revenue, strengthens balance sheet

BIAF : 0.8512 (+13.49%)
BIAFW : 0.3100 (-8.82%)
bioAffinity Technologies Announces Acceptance of Australian Patent Application for Platform to Detect and Characterize Multiple Lung Diseases

Australian patent strengthens global patent portfolio

BIAF : 0.8512 (+13.49%)
BIAFW : 0.3100 (-8.82%)
bioAffinity Technologies Presents Research Supporting CyPath® Lung Processing Methods at CHEST 2025

Visit the CyPath® Lung team at Booth #2242 October 19-22

BIAF : 0.8512 (+13.49%)
BIAFW : 0.3100 (-8.82%)
bioAffinity Technologies Secures Patent for Lung Cancer Detection

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. bioAffinity...

BIAF : 0.8512 (+13.49%)
bioAffinity Regains Nasdaq Compliance, Ensures Continued Trading

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. bioAffinity...

BIAF : 0.8512 (+13.49%)
bioAffinity Technologies Announces Notification of Allowance for U.S. Patent Application for Its Diagnostic Algorithm and Test Method for Lung Cancer

U.S. award protects AI-built platform and adds to growing international patent portfolio

BIAF : 0.8512 (+13.49%)
BIAFW : 0.3100 (-8.82%)
bioAffinity Technologies Regains Compliance with Nasdaq Listing Requirements

bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing early-stage cancer diagnostics including CyPath® Lung , the Company’s...

BIAF : 0.8512 (+13.49%)
BIAFW : 0.3100 (-8.82%)
bioAffinity Technologies Announces $1.8M Direct Offering

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An announcement...

BIAF : 0.8512 (+13.49%)

Business Summary

bioAffinity Technologies Inc. is a cancer diagnostics company which develops noninvasive, early-stage diagnostics to detect cancer and diseases of the lung and is researching targeted therapies to treat cancer. bioAffinity Technologies Inc. is based in SAN ANTONIO.

See More

Key Turning Points

3rd Resistance Point 1.1030
2nd Resistance Point 1.0013
1st Resistance Point 0.9263
Last Price 0.8512
1st Support Level 0.7496
2nd Support Level 0.6479
3rd Support Level 0.5729

See More

52-Week High 46.5300
Fibonacci 61.8% 29.0203
Fibonacci 50% 23.6115
Fibonacci 38.2% 18.2027
Last Price 0.8512
52-Week Low 0.6930

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar